Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 11 Dec 2025 for NEURONES, €2.8M. Read the official filing
Filing timeline
BuySaleBertrand Ducurtil
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Bertrand Ducurtil: trading record in brief
Bertrand Ducurtil (chief executive) discloses dealings in Neurones to AMF. In total, 9 filings cover trades dated from 30 September 2021 to 9 December 2025.
No open-market purchase appears, only 1 sale worth €1.0M.
On 11 December 2025 came the latest disclosure, a transaction for €709k in Neurones. Between a trade and the moment it shows up on AMF, the median delay is 5 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Companies and markets linked to Bertrand Ducurtil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
64,000 shares@ €44.3015.7% of flowActionHors plateforme de négociationISIN FR00040502502025DD1074148
16,000 shares@ €44.303.9% of flowActionHors plateforme de négociationISIN FR00040502502025DD1074150
57,000 shares@ €38.4512.2% of flowActionHors plateforme de négociationISIN FR00040502502023DD917854
150,000 shares@ €38.4532.0% of flowActionHors plateforme de négociationISIN FR00040502502023DD917856
25,000 shares@ €40.605.6% of flowActionHors plateforme de négociationISIN FR00040502502023DD914949
31,500 shares@ €35.006.1% of flowActionHors plateforme de négociationISIN FR00040502502021DD794473
126,000 shares@ €35.0024.5% of flowActionHors plateforme de négociationISIN FR00040502502021DD794458
7 of 7 declarations
